Glaxo Takes Another Shot At China: A Joint Venture to Make And Sell its Priorix Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
A collaboration between GSK and Jiangsu Walvax Biotech involves R&D to develop novel vaccines for essential public health in China.